wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40707619-98975375-97A2-40F2-8F05-6C8BC4FF64FB
Q40707619-98975375-97A2-40F2-8F05-6C8BC4FF64FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40707619-98975375-97A2-40F2-8F05-6C8BC4FF64FB
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia.
P2860
Q40707619-98975375-97A2-40F2-8F05-6C8BC4FF64FB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40707619-98975375-97A2-40F2-8F05-6C8BC4FF64FB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f876368fd2010f827bdd64e6475f64ac06d48566
P2860
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study.